Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Durham, N.C.-based start-up Precision BioSciences is expanding its collaboration with the University of Pennsylvania to develop therapies based on its Arcus gene editing technology, an alternative to CRISPR gene editing. The duo’s three-year partnership will use Arcus to inactivate genes in nonhuman primates. Penn’s famous gene therapy scientist, James Wilson, recently used Arcus to inactivate a gene called PCSK9 and lower cholesterol in macaques (Nat. Biotechnol. 2018, DOI: 10.1038/nbt.4182). The pair may also develop therapies to repair or introduce genes with Arcus.
This article has been sent to the following recipient: